MARKER THERAPEUTICS, INC - 9 Year Stock Price History | MRKR

The latest closing stock price for MARKER THERAPEUTICS, INC as of February 21, 2025 is 1.57.

  • An investor who bought $1,000 worth of MARKER THERAPEUTICS, INC stock at the IPO in 2016 would have $-971 today, roughly -1 times their original investment - a -35.84% compound annual growth rate over 8 years.
  • The all-time high MARKER THERAPEUTICS, INC stock closing price was 123.30 on June 18, 2018.
  • The MARKER THERAPEUTICS, INC 52-week high stock price is 5.99, which is 281.5% above the current share price.
  • The MARKER THERAPEUTICS, INC 52-week low stock price is 1.48, which is 5.7% below the current share price.
  • The average MARKER THERAPEUTICS, INC stock price for the last 52 weeks is 3.70.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.

MARKER THERAPEUTICS, INC - 9 Year Stock Price History | MRKR

  • An investor who bought $1,000 worth of MARKER THERAPEUTICS, INC stock at the IPO in 2016 would have $-971 today, roughly -1 times their original investment - a -35.84% compound annual growth rate over 8 years.
  • The all-time high MARKER THERAPEUTICS, INC stock closing price was 123.30 on June 18, 2018.
  • The MARKER THERAPEUTICS, INC 52-week high stock price is 5.99, which is 281.5% above the current share price.
  • The MARKER THERAPEUTICS, INC 52-week low stock price is 1.48, which is 5.7% below the current share price.
  • The average MARKER THERAPEUTICS, INC stock price for the last 52 weeks is 3.70.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Related Stocks
Company NameMarket
Cap
Chugai Pharmaceutical (CHGCY)$80.4B
Zoetis (ZTS)$70.5B
Takeda Pharmaceutical (TAK)$44.1B
Daiichi Sankyo, - (DSNKY)$43.3B
Sandoz Group AG (SDZNY)$20.6B
Merck (MKKGY)$18.5B
Astellas Pharma (ALPMY)$17.5B
Summit Therapeutics (SMMT)$17B
United Therapeutics (UTHR)$16.4B
Shionogi (SGIOY)$12.3B
Neurocrine Biosciences (NBIX)$11.6B
Orion OYJ (ORINY)$7.7B
Madrigal Pharmaceuticals (MDGL)$7.7B
Corcept Therapeutics (CORT)$6.8B
Hikma Pharmaceuticals Plc (HKMPF)$6.2B
Stevanato Group S.p.A (STVN)$6.2B
Ionis Pharmaceuticals (IONS)$5.2B
Grifols, S.A (GRFS)$5.2B
Ono Pharmaceutical (OPHLF)$4.7B
Recursion Pharmaceuticals (RXRX)$4B
Crinetics Pharmaceuticals (CRNX)$3.4B
Catalyst Pharmaceuticals (CPRX)$2.6B
AMNEAL PHARMACEUTICALS, INC (AMRX)$2.4B
Centessa Pharmaceuticals (CNTA)$2.2B
Hypermarcas (HYPMY)$2.2B
Soleno Therapeutics (SLNO)$2B
BioCryst Pharmaceuticals (BCRX)$1.9B
NewAmsterdam Pharma (NAMS)$1.8B
Evotec AG (EVO)$1.6B
Dyne Therapeutics (DYN)$1.4B